<- Go Home
Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business. The company also engages in key pharmaceutical intermediates, APIs, and formulations activities. The company was founded in 1998 and is headquartered in Tianjin, China.
Market Cap
CNY 26.9B
Volume
4.7M
Cash and Equivalents
CNY 5.8B
EBITDA
CNY 1.1B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
CNY 2.4B
Profit Margin
41.55%
52 Week High
CNY 94.28
52 Week Low
CNY 59.55
Dividend
1.42%
Price / Book Value
1.62
Price / Earnings
28.89
Price / Tangible Book Value
1.68
Enterprise Value
CNY 19.6B
Enterprise Value / EBITDA
17.60
Operating Income
CNY 618.7M
Return on Equity
5.44%
Return on Assets
1.98
Cash and Short Term Investments
CNY 7.6B
Debt
CNY 324.8M
Equity
CNY 16.9B
Revenue
CNY 5.8B
Unlevered FCF
-CNY 425.2M
Sector
Pharmaceuticals
Category
N/A